Recombinant IL-6 treatment exacerbates atherosclerosis in wild-type and atherosclerosis-prone ApoE−/− mice fed with a high-fat diet, which shows a dramatically increased lesion size [26]. This evidence concerns the gene IL6 and atherosclerosis.